The role of multiple sclerosis therapies on the dynamic of human gut microbiota

Also available in

Open AccessPublished:April 07, 2023DOI:


Gut microbiota, the total microorganisms in our gastrointestinal tract, might have an implication in multiple sclerosis (MS), a demyelinating neurological disease. Our study included 50 MS patients and 21 healthy controls (HC). Twenty patients received a disease modifying therapy (DMT), interferon beta1a or teriflunomide, 19 DMT combined with homeopathy and 11 patients accepted only homeopathy.


Read full text

Share on social media:

Related articles